These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 2694210

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Erythropoietin for anemia.
    Med Lett Drugs Ther; 1989 Sep 22; 31(801):85-6. PubMed ID: 2671624
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of anaemia of progressive renal failure with recombinant human erythropoietin. A preliminary report.
    Salim KA, Salim S, Mathew T.
    J Assoc Physicians India; 1992 Jan 22; 40(1):42-3. PubMed ID: 1634463
    [Abstract] [Full Text] [Related]

  • 5. Recombinant human erythropoietin (rHuEPO) in the treatment of anaemia of chronic renal failure.
    Desai JD, Shah BV.
    J Assoc Physicians India; 1991 Jun 22; 39(6):483-5. PubMed ID: 1938855
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease.
    Bommer J, Kugel M, Schoeppe W, Brunkhorst R, Samtleben W, Bramsiepe P, Scigalla P.
    Contrib Nephrol; 1988 Jun 22; 66():85-93. PubMed ID: 3292151
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Erythropoietin therapy in patients with chronic renal failure.
    Pinevich AJ, Petersen J.
    West J Med; 1992 Aug 22; 157(2):154-7. PubMed ID: 1441466
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Erythropoietin, an update, and where to in the future?
    Sulková S.
    EDTNA ERCA J; 1998 Aug 22; 24(3):30-2, 35. PubMed ID: 10392076
    [Abstract] [Full Text] [Related]

  • 14. Early intervention with recombinant human erythropoietin therapy.
    Teehan BP, Benz RL, Sigler MH, Brown JM.
    Semin Nephrol; 1990 Mar 22; 10(2 Suppl 1):28-34. PubMed ID: 2192414
    [No Abstract] [Full Text] [Related]

  • 15. Use of recombinant erythropoietin in the treatment of anaemia associated with multiple myeloma in a haemodialysis patient.
    Hussein MM, Mooij JM, Roujouleh H.
    Nephrol Dial Transplant; 1994 Mar 22; 9(7):876-7. PubMed ID: 7818713
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease.
    Kühn K, Nonnast-Daniel B, Grützmacher P, Grüner J, Pfåffl W, Baldamus CA, Scigalla P.
    Contrib Nephrol; 1988 Mar 22; 66():94-103. PubMed ID: 3292152
    [No Abstract] [Full Text] [Related]

  • 18. Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.
    Binkley LS.
    Transplant Proc; 1991 Apr 22; 23(2):1831-2. PubMed ID: 2053169
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.